Bernita Tramonte, Surviving Widow of Angelo Tramonte v. Fibreboard Corporation

947 F.2d 762, 34 Fed. R. Serv. 1167, 1991 U.S. App. LEXIS 27338, 1991 WL 225739
CourtCourt of Appeals for the Fifth Circuit
DecidedNovember 21, 1991
Docket90-4637
StatusPublished
Cited by14 cases

This text of 947 F.2d 762 (Bernita Tramonte, Surviving Widow of Angelo Tramonte v. Fibreboard Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bernita Tramonte, Surviving Widow of Angelo Tramonte v. Fibreboard Corporation, 947 F.2d 762, 34 Fed. R. Serv. 1167, 1991 U.S. App. LEXIS 27338, 1991 WL 225739 (5th Cir. 1991).

Opinion

PER CURIAM:

Bernita Tramonte and other survivors of Angelo Tramonte, Sr. (the Tramontes) appeal the district court’s decision to exclude the deposition testimony of Dr. Daniel Jenkins as rebuttal evidence. Finding that the district court did not abuse its discretion in excluding the testimony, we affirm.

I. BACKGROUND AND PROCEDURAL HISTORY

Angelo Tramonte, Sr. sued various manufacturers of asbestos-containing insulation products, alleging that he contracted an asbestos-related lung cancer as a result of his contact with those products while employed as an insulator. Mr. Tramonte died in 1987. His widow and surviving children continued the suit, and amended it to include a wrongful death action.

The key issue in the case was whether Mr. Tramonte had asbestosis, a diffuse scarring of the lungs caused by excessive asbestos exposure, which would causally link his lung cancer to asbestos exposure. At trial, the Tramontes presented five medical expert witnesses who testified that asbestos exposure was a causal factor in Mr. Tramonte’s lung cancer. Although the Tramontes offered the deposition of another medical expert, Dr. Daniel Jenkins, who had examined Mr. Tramonte in 1978, the trial court ruled that this deposition testimony was inadmissible in their case in chief. 1

The defendant asbestos companies countered by presenting experts who testified that they found no evidence of asbestosis. On direct examination, defendants asked their expert Dr. Robert O’Neal whether any of the doctors involved in Mr. Tra-monte’s treatment in Lake Charles had diagnosed his condition as asbestosis. Dr. O’Neal responded that it was never diagnosed on x-ray or clinically. Defense counsel then asked Dr. O’Neal if he had reviewed the medical records from Mr. Tra-monte’s spring 1986 visit to M.D. Anderson Cancer Treatment Center in Houston, and whether any of the doctors who saw him then had diagnosed asbestosis on any of the x-rays that they had reviewed. Dr. O’Neal testified that they had not.

On cross-examination, counsel for the Tramontes asked Dr. O’Neal if he had re *764 viewed the records of Dr. Daniel Jenkins’ 1978 consultation with Mr. Tramonte. Dr. O’Neal indicated that he had. In a side bar discussion, defense counsel objected that plaintiff was attempting to introduce the deposition opinion of Dr. Jenkins during the cross-examination of Dr. O’Neal when the court had already excluded it from the Tramontes’ case in chief. After the jury was excused, the Tramontes’ attorney attempted to lay a foundation to pursue this line of inquiry. The Tramontes’ attorney asked Dr. O’Neal to comment on a specific portion of Dr. Jenkins’ report, which stated: “There is some increase in bronchovas-cular marking into the periphery of both the right and left lungs, particularly in the mid and lower lung fields suggesting possible interstitial disease.” Dr. O’Neal indicated that this language could describe early asbestosis, but that it also could describe the condition of someone with a history of heavy cigarette smoking, such as Mr. Tra-monte. The trial court sustained the defense objection to this line of cross-examination, noting that Dr. Jenkins did not attribute the described condition to any specific disease in his report.

Following the defense’s case in chief, counsel for the Tramontes offered the medical report and deposition of Dr. Jenkins as rebuttal evidence. Defense counsel objected, pointing out that they had not introduced any evidence about Dr. Jenkins during Dr. O’Neal’s direct testimony, and that Dr. Jenkins had not diagnosed asbestosis in his report. Counsel for the Tra-montes contended that Dr. Jenkins had diagnosed Mr. Tramonte’s condition as asbestosis in his deposition testimony. However, he conceded that Dr. O’Neal had not reviewed Dr. Jenkins’ deposition. In deciding to exclude Dr. Jenkins’ deposition, the district judge observed that while Dr. Jenkins’ deposition did not need to appear on the Tramontes’ “will call” witness list to be admitted on rebuttal, it could not properly be classified as rebuttal or impeachment evidence because (1) it did not address an issue raised on direct examination, and (2) Dr. O’Neal never saw the deposition. For these reasons, the district judge concluded that the Tramontes could not avoid the earlier ruling excluding Dr. Jenkins’ deposition from evidence in the case in chief by bringing it in on rebuttal.

The Tramontes appeal the district court’s ruling on two grounds. First, they assert that Dr. Jenkins’ medical report and deposition testimony should have been admitted as rebuttal evidence because they directly contradicted Dr. O’Neal’s testimony that Mr. Tramonte had never been diagnosed with asbestosis, and their exclusion left this deliberate false impression in the minds of the jurors. Second, they argue that the district court failed to give due consideration to the insignificant prejudicial or disruptive effect the admission of this evidence would have on the trial process. We address these contentions separately below.

II. ANALYSIS

“The scope of rebuttal testimony is ordinarily a matter to be left to the sound discretion of the trial judge.” United States v. Winkle, 587 F.2d 705, 712 (5th Cir.) (citations omitted), cert. denied, 444 U.S. 827, 100 S.Ct. 51, 62 L.Ed.2d 34 (1979). Thus, we will not overturn a district court’s refusal to allow an expert to testify as a rebuttal witness unless that refusal was an abuse of discretion. Rodriguez v. Olin Corp., 780 F.2d 491, 494 (5th Cir.1986).

The trial court generally admits rebuttal evidence either to counter facts presented in the defendant’s case in chief, McVey v. Phillips Petroleum Co., 288 F.2d 53, 54 (5th Cir.1961), or to rebut evidence unavailable earlier through no fault of the plaintiff, Allen v. Prince George’s County, 737 F.2d 1299, 1305 (4th Cir.1984). The potential for unfairness to the opponent and confusion of the issues militates against admitting new or repetitive evidence at the rebuttal stage. See generally 6 John Henry Wigmore, Wigmore on Evidence § 1873 (James H. Chadbourn ed., 1976). When a plaintiff makes its prima facie case, therefore, it also must offer evidence on any other issue of potential importance to the outcome in its case in chief. Russo v. Peikes, 71 F.R.D. 110, 113 *765 (E.D.Pa.1976), aff'd, 547 F.2d 1163 (3d Cir. 1977).

First, the Tramontes contend that Dr. Jenkins’ deposition testimony and medical reports are proper rebuttal evidence because they directly contradict Dr. O’Neal’s assertion that none of the doctors who saw Angelo Tramonte attributed his cancer to asbestos exposure. The Tramontes mischaracterize Dr. O’Neal’s statement. It is clear from the record that Dr. O’Neal responded to specific questions framed by defense counsel. Defense counsel did not ask Dr. O’Neal about Mr. Tramonte’s 1978 visit to Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
947 F.2d 762, 34 Fed. R. Serv. 1167, 1991 U.S. App. LEXIS 27338, 1991 WL 225739, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bernita-tramonte-surviving-widow-of-angelo-tramonte-v-fibreboard-ca5-1991.